In recent years, the zoonotic disease treatment market is anticipated to grow rapidly during the forecast period. Depending on the infection, aetiology, and treatment, zoonotic disease can range from mild to deadly and even result in death. According to the World Health Organization (WHO), zoonotic diseases cause over one billion infections and millions of deaths each year, accounting for 60% of all new infectious diseases globally. A rise in zoonotic infections is also being attributed to a crowded environment, poor hygiene, climate and habitat changes, animal raising, and a lack of understanding. Diagnostics, treatment, and vaccine development are moving rapidly, further enhancing the demand for zoonotic disease treatment in the market.
Frequently Asked Questions
The market is segmented based on Segmentation, By Types (Rabies, Tuberculosis, Malaria, Leishmaniasis, Ebola Virus Disease, Others), Causative Agent (Bacteria, Virus, Nematode, Rodents, Ticks, Others), Drug Class (Anti-fungal, Anti-bacterial, Antibiotics, Others), Route of Administration (Oral, Topical, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2032.
.
The Global Zoonotic Disease Treatment Market size was valued at USD 43.59 USD Billion in 2024.
The Global Zoonotic Disease Treatment Market is projected to grow at a CAGR of 5.76% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
